Rejected at 6:42 p.m. Oct, 31, 2023 ] by Dam_Doc
Author: pdk001
Related Note: 1481330918238
Rationale for change

from the most recent version of pathoma:
"2. In reactive polycythemia due to high altitude or lung disease, Sao2 is low, and EPO is increased.
3. In reactive polycythemia due to ectpoic EPO production from renal cell carcinoma, EPO is high, and Sao2 is normal"

Rejection reason

agreed with PainfulMilkLeg. high altitude is Physiologically appropriate secondary polycythemia and RCC is Physiologically inappropriate secondary polycythemia

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
* b/c dehydration/burns decrease plasma volume with normal RBC mass/O2 sat/EPO levels


Watch Polycythemia



Watch Erythropoietin
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
Other:
One by one
Empty field
#AK_Step1_v12::^Systems::HemeOnc::WBC !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::30_Polycythemia #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::03_Polycythemia #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::#B&B::07_Hematology_&_Oncology::03_White_Cells::02_Myeloproliferative_Disorders #AK_Step1_v12::#B&B::11_Hematology::03_WBC::07_Myeloproliferative_Disorders #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step1_v12::#SketchyPhysiology::07_Respiratory_Physiology::03_Oxygen_Transport::03_Erythropoietin #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::02_Myeloproliferation #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::04_Pathology::30_Polycythemia::Relative_Polycythemia #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#Pathoma::06_WBC::04_Myeloproliferative